Skip to Content

HH 327 (Hydrochlorothiazide and Irbesartan 12.5 mg / 300 mg)

Pill with imprint HH 327 is Pink, Capsule-shape and has been identified as Hydrochlorothiazide and Irbesartan 12.5 mg / 300 mg. It is supplied by Solco Healthcare U.S., LLC.

Hydrochlorothiazide/irbesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/irbesartan 12.5 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for HH 327

Hydrochlorothiazide and irbesartan 12.5 mg / 300 mg HH 327
Hydrochlorothiazide and irbesartan 12.5 mg / 300 mg HH 327 Front
Hydrochlorothiazide and irbesartan 12.5 mg / 300 mg HH 327 Back
Hydrochlorothiazide and irbesartan 12.5 mg / 300 mg HH 327
Hydrochlorothiazide and irbesartan 12.5 mg / 300 mg HH 327

Hydrochlorothiazide and Irbesartan

Imprint
HH 327
Strength
12.5 mg / 300 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Angiotensin II inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Solco Healthcare U.S., LLC
Manufacturer
Zhejiang Huahai Pharmaceutical Co., Ltd.
National Drug Code (NDC)
43547-0331

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.